HLN · Haleon plc · Webcasts, Transcripts & Audio
$9.02
-0.07 (-0.72%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$39.50B
Shares
4.38B
Volume · Nov 19
4.5M
Avg daily vol (3M)
18.85M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Haleon plc Webcasts
Earnings calls, investor updates, investor days and conferences for Haleon plc (HLN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-29
Haleon plc (HLN) Q3 2026 Earnings Call Transcript
Balanced tone
Q3 performance shortfall
North America commercial execution
European market conditions
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-30
Haleon plc (HLN) Q2 2026 Earnings Call Transcript
Confident tone
Emerging markets growth engine
win-is-won strategy and medium-term guidance
North America execution and recovery
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
Haleon plc (HLN) Q1 2026 Earnings Call Transcript
Positive tone
Cold and Flu / Respiratory
E-commerce / China
Middle East / Geopolitical Risk
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Positive tone
Emerging markets performance (India, China, LatAm, EMEA)
Oral Health category strength and shelf resets
A&P investment and innovation
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Haleon plc (HLN) Q3 2025 Earnings Call Transcript
Positive tone
North America softness and outlook
Emerging markets (India, LatAm, APAC)
Oral Health and Sensodyne
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Haleon plc (HLN) Q2 2025 Earnings Call Transcript
Balanced tone
Oral Health and Digestive Health Strength
Emerging Markets Growth
Advil and Centrum Recovery
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Haleon plc (HLN) Q1 2025 Earnings Call Transcript
Positive tone
Emerging markets performance
Innovation and product launches
Organic revenue growth and guidance
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
Haleon plc (HLN) Q4 2024 Earnings Call Transcript
Positive tone
Oral Health and Innovation
2025 Guidance and Quarterly Phasing
Emerging Markets: India and China
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Haleon plc (HLN) Q2 2024 Earnings Call Transcript
Confident tone
Eroxon launch and product innovation
Category dynamics (Pain Relief, Respi, Oral Health, VMS)
Margin and A&P investment in H2
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Haleon plc (HLN) Q1 2024 Earnings Call Transcript
Positive tone
U.S. volume softness and retailer inventory adjustments
Pain relief and respiratory comparatives
Organic revenue growth and full-year guidance
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Haleon plc (HLN) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–12 of 12 webcasts
Key facts
CIK
1900304
CUSIP
405552100
13F (30d)
632 filings
565 filers
Visit website
Investor relations